Examining the Safety Profile of Janus Kinase (JAK) Inhibitors in the Management of Immune-Mediated Diseases: A Comprehensive Review.
Life (Basel)
; 13(12)2023 Nov 22.
Article
in En
| MEDLINE
| ID: mdl-38137845
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Life (Basel)
Year:
2023
Document type:
Article
Affiliation country:
Bulgaria
Country of publication:
Switzerland